Loading data
RLMDNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 26.88 m USD | 46.18 m USD | 54.81 m USD | 113.32 m USD | 90.62 m USD |
| Operating profit | -59.1 m USD | -83.89 m USD | -103.7 m USD | -161.25 m USD | -125.7 m USD |
| Net income (reported basis) | 0 USD | 0 USD | 0 USD | 0 USD | -125.75 m USD |
| Basic earnings per share | -1.45 USD/share | -2.65 USD/share | -3.28 USD/share | -5.3 USD/share | -7.16 USD/share |
| Diluted earnings per share | -1.45 USD/share | -2.65 USD/share | -3.28 USD/share | -5.3 USD/share | -7.16 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.